As of 2025-07-04, the Relative Valuation of Design Therapeutics Inc (DSGN) is (13.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.52 USD, the upside of Design Therapeutics Inc based on Relative Valuation is -473.7%.
The range of the Relative Valuation is (12.91) - (18.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 18.3x | 12.9x |
| Forward P/E multiples | 12.5x - 20.7x | 13.3x |
| Fair Price | (12.91) - (18.33) | (13.15) |
| Upside | -466.8% - -620.9% | -473.7% |
| Date | P/E |
| 2025-07-01 | -3.51 |
| 2025-06-30 | -3.36 |
| 2025-06-27 | -3.56 |
| 2025-06-26 | -3.80 |
| 2025-06-25 | -3.93 |
| 2025-06-24 | -3.95 |
| 2025-06-23 | -3.88 |
| 2025-06-20 | -3.72 |
| 2025-06-18 | -3.77 |
| 2025-06-17 | -3.67 |
| 2025-06-16 | -3.85 |
| 2025-06-13 | -3.82 |
| 2025-06-12 | -3.89 |
| 2025-06-11 | -3.88 |
| 2025-06-10 | -3.99 |
| 2025-06-09 | -3.89 |
| 2025-06-06 | -3.99 |
| 2025-06-05 | -3.98 |
| 2025-06-04 | -4.08 |
| 2025-06-03 | -3.99 |
| 2025-06-02 | -4.00 |
| 2025-05-30 | -3.71 |
| 2025-05-29 | -3.99 |
| 2025-05-28 | -3.98 |
| 2025-05-27 | -3.86 |
| 2025-05-23 | -3.79 |
| 2025-05-22 | -3.85 |
| 2025-05-21 | -3.59 |
| 2025-05-20 | -3.66 |
| 2025-05-19 | -3.52 |
| 2025-05-16 | -3.50 |
| 2025-05-15 | -3.35 |
| 2025-05-14 | -3.20 |
| 2025-05-13 | -3.56 |
| 2025-05-12 | -3.61 |
| 2025-05-09 | -3.49 |
| 2025-05-08 | -3.51 |
| 2025-05-07 | -3.32 |
| 2025-05-06 | -3.62 |
| 2025-05-05 | -4.34 |
| 2025-05-02 | -4.63 |
| 2025-05-01 | -4.69 |
| 2025-04-30 | -4.84 |
| 2025-04-29 | -4.37 |
| 2025-04-28 | -4.04 |
| 2025-04-25 | -3.86 |
| 2025-04-24 | -4.22 |
| 2025-04-23 | -4.05 |
| 2025-04-22 | -3.94 |
| 2025-04-21 | -3.58 |